يعرض 1 - 20 نتائج من 20,791 نتيجة بحث عن '"Agitation"', وقت الاستعلام: 0.62s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المؤلفون: Garrote Cámara, María Elena

    المساهمون: University/Department: Universitat de Lleida. Departament d'Infermeria i Fisioteràpia

    Thesis Advisors: Juárez Vela, Raúl, Santolalla Arnedo, Iván, Rubinat, Esther

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  2. 2
    Report

    المساهمون: Dave Shade, Director, S-CitAD Coordinating Center

    المصدر: Escitalopram for Agitation in Alzheimer's Disease
    Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group. Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement. 2019 Nov;15(11):1427-1436. doi: 10.1016/j.jalz.2019.06.4946. Epub 2019 Oct 3.

  3. 3
    Report

    المصدر: A Phase 2a, Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

  4. 4
    Report

    المؤلفون: Worldwide Clinical Trials

    المصدر: Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder

  5. 5
    Report
  6. 6
    Report

    المصدر: A Phase 3, Multicenter, Long Term, Extension Study of the Safety and Efficacy of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  7. 7
    Report

    المصدر: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  8. 8
    Report

    المصدر: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  9. 9
    Report

    المصدر: An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Dementia of the Alzheimer's Type

  10. 10
    Report

    المصدر: ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: a Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease Agitation

  11. 11
    Report

    المساهمون: Bernard (Barry) Baumel, Associate Professor of Neurology

    المصدر: A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities From Alzheimer's Disease.

  12. 12
    Report

    المصدر: A Phase 1b, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

  13. 13
    Report

    المصدر: A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease

  14. 14
    Report

    المساهمون: Lone Baandrup, Head of Clinic, clinical associate research professor

    المصدر: Advancing the Quality of Treatment and Care for Acute Agitation in Emergency Psychiatry

  15. 15
    Report

    المصدر: Nabilone for Agitation Blinded Intervention Trial
    Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctot KL. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. Am J Geriatr Psychiatry. 2019 Nov;27(11):1161-1173. doi: 10.1016/j.jagp.2019.05.002. Epub 2019 May 8.

  16. 16
    Report

    المصدر: Effects of PNF Stretching vs Conventional Physical Therapy on the Symptoms of Restless Leg Syndrome in Elderly Population.

  17. 17
    Report

    المصدر: An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects with Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

  18. 18
    Report

    المساهمون: Bomi Framroze, Principal Investigator

    المصدر: Gene Expression Changes on Extended Use of Dopamine Agonists in Restless Legs Syndrome (RLS)

  19. 19
    Periodical

    المؤلفون: BENDLE, MERVYN

    المصدر: Quadrant Magazine. Sep2024, Vol. 68 Issue 9, p52-57. 6p.

    مصطلحات موضوعية: *ANXIETY, *AGITATION (Psychology), *MORTALITY, *DEMOGRAPHY, *DEATH

  20. 20
    Report

    المساهمون: Emmanuel Mignot, Craig Reynolds Professor of Sleep Medicine

    المصدر: Proteomic Response to Exercise in Adults With Restless Legs Syndrome